Immune Tolerance Network   

A clinical research consortium sponsored by NIAID

Participating

Mother hugging daughter at the beach.Participating in RESTARRT

As a participant in RESTARRT, you will receive:

  • the experimental medications (ATG and Rituximab) at no cost to you
  • regular and frequent monitoring of your health and the health of your transplanted kidney by the RESTARRT team of transplant experts
  • the opportunity to gradually reduce and possibly reduce immunosuppressive drugs under close medical supervision

Participation may last up to four and a half years.

Contact the RESTARRT transplant team near you for more information about the study.

Click here to review the benefits and risks of transplant therapy.